AG2034
Code | Size | Price |
---|
TAR-T26572-5mg | 5mg | £1,813.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26572-50mg | 50mg | £3,589.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26572-100mg | 100mg | £4,970.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
AG2034 is an inhibitor of the glycinamide ribonucleotide formyltransferase (GARFT).
CAS:
177575-17-6
Formula:
C18H21N5O6S2
Molecular Weight:
467.52
Purity:
0.98
SMILES:
Nc1nc(=O)c2S[C@@H](CCc3ccc(s3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1
References
1. Peterson JJ. A review of synergy concepts of nonlinear blending and dose-reduction profiles. Front Biosci (Schol Ed). 2010 Jan 1;2:483-503. Review. PubMed PMID: 20036963.
2. Lee JJ, Lin HY, Liu DD, Kong M. Emax model and interaction index for assessing drug interaction in combination studies. Front Biosci (Elite Ed). 2010 Jan 1;2:582-601. PubMed PMID: 20036904; PubMed Central PMCID: PMC2974574.
3. Kong M, Lee JJ. Applying Emax model and bivariate thin plate splines to assess drug interactions. Front Biosci (Elite Ed). 2010 Jan 1;2:279-92. PubMed PMID: 20036878; PubMed Central PMCID: PMC4203317.
4. Straetemans R, Bijnens L. Application and review of the separate ray model to investigate interaction effects. Front Biosci (Elite Ed). 2010 Jan 1;2:266-78. PubMed PMID: 20036877.